Hostname: page-component-74656f9884-rdgjk Total loading time: 0 Render date: 2026-11-07T07:51:57.314Z Has data issue: false hasContentIssue false

Subclinical psychosis syndromes in the general population: results from a large-scale epidemiological survey among residents of the canton of Zurich, Switzerland

Published online by Cambridge University Press:  26 November 2013

W. Rössler*
Affiliation:
University Hospital of Psychiatry, Zurich Programme for Sustainable Development of Mental Health Services, Zurich, Switzerland University of Zurich and ETHZ, Collegium Helveticum Zurich, Zurich, Switzerland Laboratory of Neuroscience – LIM 27, Institute of Psychiatry, University of Sao Paulo, Sao Paulo, Brazil
V. Ajdacic-Gross
Affiliation:
University Hospital of Psychiatry, Zurich Programme for Sustainable Development of Mental Health Services, Zurich, Switzerland Laboratory of Neuroscience – LIM 27, Institute of Psychiatry, University of Sao Paulo, Sao Paulo, Brazil
H. Haker
Affiliation:
University Hospital of Psychiatry, Zurich Programme for Sustainable Development of Mental Health Services, Zurich, Switzerland Translational Neuromodeling Unit, Institute for Biomedical Engineering, University of Zurich & ETH Zurich, Zurich, Switzerland
S. Rodgers
Affiliation:
University Hospital of Psychiatry, Zurich Programme for Sustainable Development of Mental Health Services, Zurich, Switzerland
M. Müller
Affiliation:
University Hospital of Psychiatry, Zurich Programme for Sustainable Development of Mental Health Services, Zurich, Switzerland
M. P. Hengartner
Affiliation:
University Hospital of Psychiatry, Zurich Programme for Sustainable Development of Mental Health Services, Zurich, Switzerland
*
* Address for correspondence: Dr Wulf Rössler, Psychiatric University Hospital, University of Zurich, Militärstrasse 8, CH-8004 Zurich, Switzerland (Email: roessler@dgsp.uzh.ch)
Rights & Permissions [Opens in a new window]

Abstract

Aims.

Prevalence and covariates of subclinical psychosis have gained increased interest in the context of early identification and treatment of persons at risk for psychosis.

Methods.

We analysed 9829 adults representative of the general population within the canton of Zurich, Switzerland. Two psychosis syndromes, derived from the SCL-90-R, were applied: ‘schizotypal signs’ and ‘schizophrenia nuclear symptoms’.

Results.

Only a few subjects (13.2%) reported no schizotypal signs. While 33.2% of subjects indicated mild signs, only a small proportion (3.7%) reported severe signs. A very common outcome was no ‘schizophrenia nuclear symptoms’ (70.6%). Although 13.5% of the participants reported mild symptoms, severe nuclear symptoms were very rare (0.5%). Because these two syndromes were only moderately correlated (r = 0.43), we were able to establish sufficiently distinct symptom clusters. Schizotypal signs were more closely connected to distress than was schizophrenia nuclear symptoms, even though their distribution types were similar. Both syndromes were associated with several covariates, such as alcohol and tobacco use, being unmarried, low education level, psychopathological distress and low subjective well-being.

Conclusions.

Subclinical psychosis symptoms are quite frequent in the general population but, for the most part, are not very pronounced. In particular, our data support the notion of a continuous Wald distribution of psychotic symptoms in the general population. Our findings have enabled us to confirm the usefulness of these syndromes as previously assessed in other independent community samples. Both can appropriately be associated with well-known risk factors of schizophrenia.

Information

Type
Original Articles
Copyright
Copyright © Cambridge University Press 2013 
Figure 0

Table 1. Items for the new subscales of ‘schizophrenia nuclear symptoms’ and ‘schizotypal signs’ that replace those for the ‘paranoid ideation’ (PN) and ‘psychoticism’ (PS) subscales from the original SCL-90-R

Figure 1

Fig. 1. Distribution of ‘schizotypal signs’ (left) and ‘schizophrenia nuclear symptoms’ (right).

Figure 2

Table 2. Frequency of categories for ‘schizotypal signs’ and ‘schizophrenia nuclear symptoms’

Figure 3

Table 3. Contingency table of categories for distress within ‘schizotypal signs’ and ‘schizophrenia nuclear symptoms’

Figure 4

Table 4. Associations of ‘schizotypal signs’ and ‘schizophrenia nuclear symptoms’, adjusted for sex and age. Values followed by a different superscript within a column vary significantly at corrected p < 0.05

Figure 5

Table 5. Subjective appraisal of mental health in association with ‘schizotypal signs’ and ‘schizophrenia nuclear symptoms’, adjusted for sex and age. Values followed by a different superscript within a column vary significantly at corrected p < 0.05